2373-8057

npj Parkinson s Disease

Springer Science and Business Media LLC

View prefix report (10.1038)

Health Score

0 Excellent

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 567 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Medium impact567 DOIs
2

Add abstracts to 478 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Medium impact478 DOIs
3

Deposit reference lists for 119 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact119 DOIs

DOIs for this ISSN

Showing the top 5 of 1492 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Transcranial direct current stimulation for Parkinson’s dise… (10.1038/s41531-024-00821-z)
Abstract ORCID
73.12 28
2 Smartphones as new tools in the management and understanding… (10.1038/npjparkd.2016.6)
Abstract ORCID
70.75 25
3 The gut-brain axis: is intestinal inflammation a silent driv… (10.1038/s41531-016-0002-0)
ORCID
67.23 488
4 Oligodendrocyte-astrocyte crosstalk in Parkinson’s disease m… (10.1038/s41531-025-00995-0)
Abstract ORCID
65.05 19
5 Clinically probable RBD is an early predictor of malignant n… (10.1038/s41531-025-00874-8)
Abstract ORCID
63.94 18
6 Gardenia-derived extracellular vesicles exert therapeutic ef… (10.1038/s41531-025-01044-6)
Abstract ORCID
62.76 17
7 Impact of motor symptom asymmetry on non-motor outcomes in P… (10.1038/s41531-025-01046-4)
Abstract ORCID
62.76 17
8 Will adaptive deep brain stimulation for Parkinson’s disease… (10.1038/s41531-025-00974-5)
Abstract ORCID
61.52 16
9 Lipid profiling of Parkinson’s disease brain highlights disr… (10.1038/s41531-025-01023-x)
Abstract ORCID
61.52 16
10 Disruption of axonal transport in Parkinson’s disease: the r… (10.1038/s41531-025-00926-z)
Abstract ORCID
60.21 15
11 Choroid plexus enlargement contributes to motor severity via… (10.1038/s41531-025-00971-8)
Abstract ORCID
60.21 15
12 LRRK2 levels in immune cells are increased in Parkinson’s di… (10.1038/s41531-017-0010-8)
ORCID
59.68 243
13 Neuromelanin detection by magnetic resonance imaging (MRI) a… (10.1038/s41531-018-0047-3)
ORCID
59.14 231
14 Voluntary exercise alleviates neural functional deficits in… (10.1038/s41531-025-00912-5)
Abstract ORCID
58.80 14
15 High-resolution mapping of substantia nigra in Parkinson’s d… (10.1038/s41531-025-00972-7)
Abstract ORCID
58.80 14
16 A brain-shuttled antibody targeting alpha synuclein aggregat… (10.1038/s41531-025-01117-6)
Abstract ORCID
58.80 14
17 Structural basis of epitope recognition by anti-alpha-synucl… (10.1038/s41531-024-00822-y)
Abstract ORCID
57.31 13
18 VisionMD: an open-source tool for video-based analysis of mo… (10.1038/s41531-025-00876-6)
Abstract ORCID
57.31 13
19 Lysophosphatidylcholine promoting α-Synuclein aggregation in… (10.1038/s41531-025-00902-7)
Abstract ORCID
57.31 13
20 Association of Enterococcus faecalis and tyrosine decarboxyl… (10.1038/s41531-025-00903-6)
Abstract ORCID
57.31 13
21 Lactobacillus reuteri-derived γ-amino butyric acid alleviate… (10.1038/s41531-025-01022-y)
Abstract ORCID
57.31 13
22 Chronic stress induces depression-like behaviors and Parkins… (10.1038/s41531-025-00998-x)
Abstract ORCID
55.70 12
23 Mapping of catecholaminergic denervation, neurodegeneration,… (10.1038/s41531-025-00872-w)
Abstract ORCID
53.96 11
24 Sex differences in peripheral and central dysregulation of t… (10.1038/s41531-025-00949-6)
Abstract ORCID
53.96 11
25 Butyrate improves abnormal sleep architecture in a Parkinson… (10.1038/s41531-025-01029-5)
Abstract ORCID
53.96 11
26 Independent serum metabolomics approaches identify disrupted… (10.1038/s41531-025-01126-5)
Abstract ORCID
53.96 11
27 Parkinson’s disease as a system-level disorder (10.1038/npjparkd.2016.25)
ORCID
53.65 139
28 The effect of deep brain stimulation on the non-motor sympto… (10.1038/npjparkd.2016.24)
ORCID
52.85 129
29 Mitochondrial dysfunction within the synapses of substantia… (10.1038/s41531-018-0044-6)
ORCID
52.42 124
30 Cognitive decline in Parkinson’s disease: the complex pictur… (10.1038/npjparkd.2016.18)
ORCID
52.16 121
31 Common genetic variant association with altered HLA expressi… (10.1038/npjparkd.2015.2)
ORCID
52.07 120
32 TMS-evoked potentials unveil occipital network involvement i… (10.1038/s41531-024-00793-0)
Abstract ORCID
52.07 10
33 Relative sparing of dopaminergic terminals in the caudate nu… (10.1038/s41531-024-00818-8)
Abstract ORCID
52.07 10
34 Complement C4 exacerbates astrocyte-mediated neuroinflammati… (10.1038/s41531-025-01005-z)
Abstract ORCID
52.07 10
35 Differential role of C-terminal truncations on alpha-synucle… (10.1038/s41531-025-01084-y)
Abstract ORCID
52.07 10
36 Integrated molecular landscape of Parkinson’s disease (10.1038/s41531-017-0015-3)
ORCID
51.70 116
37 Imaging advances to detect non-motor prodromal markers of Pa… (10.1038/s41531-025-01004-0)
Abstract ORCID
50.00 9
38 Diffusion–tensor MRI study of the relationship between glymp… (10.1038/s41531-025-01074-0)
Abstract ORCID
50.00 9
39 Urea cycle dysregulation drives metabolic stress and neurode… (10.1038/s41531-025-01099-5)
Abstract ORCID
50.00 9
40 New perspectives on molecular mechanisms underlying exercise… (10.1038/s41531-025-01113-w)
Abstract ORCID
50.00 9
41 Delaying aging is neuroprotective in Parkinson’s disease: a… (10.1038/npjparkd.2015.22)
ORCID
48.36 85
42 Creation of a library of induced pluripotent stem cells from… (10.1038/npjparkd.2016.9)
ORCID
48.24 84
43 Infection with mosquito-borne alphavirus induces selective l… (10.1038/s41531-019-0090-8)
ORCID
48.11 83
44 Fatigue in Parkinson’s disease: report from a multidisciplin… (10.1038/npjparkd.2015.25)
ORCID
47.85 81
45 Proteasome-targeted nanobodies alleviate pathology and funct… (10.1038/s41531-018-0062-4)
ORCID
47.71 80
46 Digital phenotyping of Parkinson’s disease via natural langu… (10.1038/s41531-025-01050-8)
Abstract ORCID
47.71 8
47 Early synaptic changes and reduced brain connectivity in PD-… (10.1038/s41531-025-01073-1)
Abstract ORCID
47.71 8
48 Oligomeric alpha-synuclein causes early synaptic dysfunction… (10.1038/s41531-025-01075-z)
Abstract ORCID
47.71 8
49 Large-scale copy number variant analysis in genes linked to… (10.1038/s41531-025-01076-y)
Abstract ORCID
47.71 8
50 Online prediction of optimal deep brain stimulation contacts… (10.1038/s41531-025-01092-y)
Abstract ORCID
47.71 8